PMID: 7334388Nov 1, 1981Paper

Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease

Journal of Neurology, Neurosurgery, and Psychiatry
A J Lees, G M Stern

Abstract

The progress of 50 previously untreated patients with idiopathic Parkinson's disease taking maximum tolerated doses of bromocriptine is compared with patients who had taken levodopa. Twenty-eight of the bromocriptine treated patients showed sustained benefit for at least one year and in five this persisted longer than five years. Fewer of the late complications of levodopa therapy occurred in those taking bromocriptine; drug-induced dyskinesia was seen in only one patient and oscillations in performance were not observed. There was a tendency for deterioration to develop after two years treatment when patients then failed to respond well to levodopa. It was not possible to extend the period of effective control of disabilities by first giving bromocriptine.

References

Apr 8, 1978·Lancet·D B CalneP F Teychenne
Sep 9, 1978·Lancet·H P LudinP Lörincz
Aug 1, 1978·Archives of Neurology·A J LeesG M Stern
Nov 1, 1976·Journal of Neurology, Neurosurgery, and Psychiatry·J D ParkesC D Marsden
Oct 27, 1973·Lancet·K R HunterG M Stern
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Aug 1, 1961·The Journal of Nervous and Mental Disease·G J CANTERM MIER

❮ Previous
Next ❯

Citations

Sep 24, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·J L MontastrucJ M Senard
May 1, 1992·Annals of Neurology·M R LuquinJ A Obeso
Dec 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Alice J MansonAndrew J Lees
Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·W PoeweM Emre
Jan 1, 1987·Journal of Neural Transmission·A BraunT N Chase
Aug 28, 1990·European Journal of Pharmacology·C RouillardT Di Paolo
Mar 13, 1990·European Journal of Pharmacology·C GagnonT Di Paolo
Aug 4, 1990·Lancet·M J VidailhetY Agid
Jan 1, 1987·Pharmacology & Therapeutics·A E Lang
Jan 1, 1997·Life Sciences·G J FiciV H Sethy
Sep 29, 2000·Parkinsonism & Related Disorders·A Lledó
Jul 2, 2008·Parkinsonism & Related Disorders·C W Olanow
Oct 29, 2000·Trends in Neurosciences·D J Brooks
Jul 17, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Hanna S LindgrenM Angela Cenci
Jan 1, 1995·Fundamental & Clinical Pharmacology·P J BlanchetP J Bédard
May 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·A BraunT N Chase
Jun 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·A J Lees
May 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·M M MouradianT N Chase
Jul 23, 2003·CNS Drugs·Silvia MandelMoussa B H Youdim
Aug 19, 1999·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·P J Blanchet
Jan 1, 1986·Current Medical Research and Opinion·C Weil
May 30, 2007·Journal of Neurochemistry·Barbara ValastroMaria Angela Cenci
Dec 5, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S L Nicholson, J M Brotchie
Jan 30, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S PapapetropoulosE Chroni
Mar 9, 2018·Cell and Tissue Research·Hana YouJean-Christophe Corvol
Nov 7, 2015·Disease Models & Mechanisms·Yasir Hasan SiddiqueAlim Hussain Naqvi
Apr 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·A WrightG M Stern
Feb 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·J L JuncosT N Chase
Jan 1, 1989·Acta Neurologica Scandinavica. Supplementum·R J Hardie
Oct 26, 2000·Brain : a Journal of Neurology·A Schrag, N Quinn
Aug 1, 1987·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·R J Riopelle
Aug 1, 1985·Acta Neurologica Scandinavica·Y ToyokuraH Ito

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.